On Thursday, Lundbeck and partner Otsuk received the green light from the US Food and Drug Administration (FDA) to expand the use of the schizophrenia treatment to include patients aged 13 to 17 years, reports a shared press release.
Up to now, Rexulti has only been approved to treat adults with schizophrenia and as an adjunctive treatment of major depressive disorder. However, the younger segment is particularly important when it comes to schizophrenia, as the disorder often starts developing in adolescence.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Ambu board had started headhunting process long before firing of CEO
Thursday’s CEO change had been in the works for a while, says Ambu’s board chair Jørgen Jensen.
Nine new drugs recommended for approval by CHMP at May meeting
During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.
Britt Meelby Jensen wants to rebuild trust in Ambu
After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.
Outgoing Ambu CEO commends colleagues
”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.
Top news from MedWatch this week
Miss anything?
IRT Manager, Clinical Drug Supply 
Quality System Manager 
Consultant Manager 
Cell Culture Scientist/Senior Scientist 
Procurement Manager, Direct Materials 
Director for innovative pre-clinical testing unit 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Account Manager 
Director Global Engineering 
Procurement Process Excellence Specialist 
Key Account Manager, Europe and Asia 
(Senior) Drug Substance Specialist 
Project Manager & Scrum Master 
System Sales Development Consultant - Investment Projects, Merck Millipore